{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T18:44:52Z","timestamp":1795200292324,"version":"4.10.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mechanical pressure overload and other stimuli often contribute to heart hypertrophy, a significant factor in the induction of heart failure. The UDP-glucose ceramide glycosyltransferase (UGCG) enzyme plays a crucial role in the metabolism of sphingolipids through the production of glucosylceramide. However, its role in heart hypertrophy remains unknown. In this study, UGCG was induced in response to pressure overload in vivo and phenylephrine stimulation in vitro. Additionally, UGCG downregulation ameliorated cardiomyocyte hypertrophy, improved cardiomyocyte mitochondrial oxidative stress, and reduced the ERK signaling pathway. Conversely, UGCG overexpression in cardiomyocytes promoted heart hypertrophy development, aggravated mitochondrial oxidative stress, and stimulated ERK signaling. Furthermore, the interaction between beta-1,4-galactosyltransferase 5 (B4GalT5), which catalyses the synthesis of lactosylceramide, and UGCG was identified, which also functions as a synergistic molecule of UGCG. Notably, limiting the expression of B4GalT5 impaired the capacity of UGCG to promote myocardial hypertrophy, suggesting that B4GalT5 acts as an intermediary for UGCG. Overall, this study highlights the potential of UGCG as a modulator of heart hypertrophy, rendering it a potential target for combating heart hypertrophy.<\/jats:p>","DOI":"10.1186\/s11658-023-00484-3","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T06:02:56Z","timestamp":1693548176000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["UGCG modulates heart hypertrophy through B4GalT5-mediated mitochondrial oxidative stress and the ERK signaling pathway"],"prefix":"10.1186","volume":"28","author":[{"given":"Shengyu","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xutao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoliang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,1]]},"reference":[{"key":"484_CR1","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1172\/JCI77656","volume":"125","author":"A Lu","year":"2015","unstructured":"Lu A, Zuo C, He Y, Chen G, Piao L, Zhang J, et\u00a0al. EP3 receptor deficiency attenuates pulmonary hypertension through suppression of Rho\/TGF-beta1 signaling. J Clin Invest. 2015;125:1228\u201342.","journal-title":"J Clin Invest"},{"key":"484_CR2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","volume":"97","author":"I Shimizu","year":"2016","unstructured":"Shimizu I, Minamino T. Physiological and pathological cardiac hypertrophy. J Mol Cell Cardiol. 2016;97:245\u201362.","journal-title":"J Mol Cell Cardiol"},{"key":"484_CR3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s11658-022-00349-1","volume":"27","author":"R Zhang","year":"2022","unstructured":"Zhang R, Qu Y, Ji Z, Hao C, Su Y, Yao Y, et\u00a0al. METTL3 mediates Ang-II-induced cardiac hypertrophy through accelerating pri-miR-221\/222 maturation in an m6A-dependent manner. Cell Mol Biol Lett. 2022;27:55.","journal-title":"Cell Mol Biol Lett"},{"key":"484_CR4","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.jtcvs.2008.12.020","volume":"137","author":"YH Choi","year":"2009","unstructured":"Choi YH, Cowan DB, Moran AM, Colan SD, Stamm C, Takeuchi K, et\u00a0al. Myocyte apoptosis occurs early during the development of pressure-overload hypertrophy in infant myocardium. J Thorac Cardiovasc Surg. 2009;137:1356\u201362.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"484_CR5","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41580-020-00294-x","volume":"21","author":"KT Schjoldager","year":"2020","unstructured":"Schjoldager KT, Narimatsu Y, Joshi HJ, Clausen H. Global view of human protein glycosylation pathways and functions. Nat Rev Mol Cell Biol. 2020;21:729\u201349.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"484_CR6","first-page":"293","volume":"41","author":"W Liu","year":"2018","unstructured":"Liu W, Yan X, Liu W, Wang Y, Rao Y, Yu H, et\u00a0al. Alterations of protein glycosylation in embryonic stem cells during adipogenesis. Int J Mol Med. 2018;41:293\u2013301.","journal-title":"Int J Mol Med"},{"key":"484_CR7","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1096\/fj.201801057R","volume":"33","author":"AR Ednie","year":"2019","unstructured":"Ednie AR, Deng W, Yip KP, Bennett ES. Reduced myocyte complex N-glycosylation causes dilated cardiomyopathy. FASEB J. 2019;33:1248\u201361.","journal-title":"FASEB J"},{"key":"484_CR8","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1161\/CIRCRESAHA.121.319456","volume":"129","author":"Z Li","year":"2021","unstructured":"Li Z, Xu J, Song Y, Xin C, Liu L, Hou N, et\u00a0al. PRMT5 prevents dilated cardiomyopathy via suppression of protein O-GlcNAcylation. Circ Res. 2021;129:857\u201371.","journal-title":"Circ Res"},{"key":"484_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-022-01044-9","author":"ZB Li","year":"2023","unstructured":"Li ZB, Jiang L, Ni JD, Xu YH, Liu F, Liu WM, et\u00a0al. Salvianolic acid B suppresses hepatic fibrosis by inhibiting ceramide glucosyltransferase in hepatic stellate cells. Acta Pharmacol Sin. 2023. https:\/\/doi.org\/10.1038\/s41401-022-01044-9.","journal-title":"Acta Pharmacol Sin"},{"key":"484_CR10","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1093\/eurheartj\/ehab412","volume":"42","author":"L Andersson","year":"2021","unstructured":"Andersson L, Cinato M, Mardani I, Miljanovic A, Arif M, Koh A, et\u00a0al. Glucosylceramide synthase deficiency in the heart compromises beta1-adrenergic receptor trafficking. Eur Heart J. 2021;42:4481\u201392.","journal-title":"Eur Heart J"},{"key":"484_CR11","volume":"4","author":"H Zhou","year":"2013","unstructured":"Zhou H, Ma H, Wei W, Ji D, Song X, Sun J, et\u00a0al. B4GALT family mediates the multidrug resistance of human leukemia cells by regulating the hedgehog pathway and the expression of p-glycoprotein and multidrug resistance-associated protein 1. Cell Death Dis. 2013;4: e654.","journal-title":"Cell Death Dis"},{"key":"484_CR12","first-page":"1084","volume":"52","author":"W Tang","year":"2020","unstructured":"Tang W, Li M, Qi X, Li J. Beta1,4-galactosyltransferase V modulates breast cancer stem cells through wnt\/beta-catenin signaling pathway. Cancer Res Treat. 2020;52:1084\u2013102.","journal-title":"Cancer Res Treat"},{"key":"484_CR13","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.bbalip.2019.04.016","volume":"1864","author":"M Rakhshandehroo","year":"2019","unstructured":"Rakhshandehroo M, van Eijkeren RJ, Gabriel TL, de Haar C, Gijzel SMW, Hamers N, et\u00a0al. Adipocytes harbor a glucosylceramide biosynthesis pathway involved in iNKT cell activation. Biochim Biophys Acta Mol Cell Biol Lipids. 2019;1864:1157\u201367.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"484_CR14","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/s41401-020-00587-z","volume":"42","author":"SQ Ma","year":"2021","unstructured":"Ma SQ, Guo Z, Liu FY, Hasan SG, Yang D, Tang N, et\u00a0al. 6-Gingerol protects against cardiac remodeling by inhibiting the p38 mitogen-activated protein kinase pathway. Acta Pharmacol Sin. 2021;42:1575\u201386.","journal-title":"Acta Pharmacol Sin"},{"key":"484_CR15","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1097\/CM9.0000000000002540","volume":"135","author":"S Cui","year":"2022","unstructured":"Cui S, Li Y, Zhang X, Wu B, Li M, Gao J, et\u00a0al. Fibroblast growth factor 5 overexpression ameliorated lipopolysaccharide-induced apoptosis of hepatocytes through regulation of the phosphoinositide-3-kinase\/protein kinase B pathway. Chin Med J (Engl). 2022;135:2859\u201368.","journal-title":"Chin Med J (Engl)"},{"key":"484_CR16","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109158","volume":"111","author":"C Shengyu","year":"2022","unstructured":"Shengyu C, Yinhua L, Yuanhong L, Jinbo Z, Can F, Hao X, et\u00a0al. Selenium alleviates heart remodeling through Sirt1\/AKT\/GSK-3beta pathway. Int Immunopharmacol. 2022;111: 109158.","journal-title":"Int Immunopharmacol"},{"key":"484_CR17","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.122.321431","volume":"131","author":"P Umbarkar","year":"2022","unstructured":"Umbarkar P, Tousif S, Singh AP, Anderson JC, Zhang Q, Tallquist MD, et\u00a0al. Fibroblast GSK-3alpha promotes fibrosis via RAF-MEK-ERK pathway in the injured heart. Circ Res. 2022;131:620\u201336.","journal-title":"Circ Res"},{"key":"484_CR18","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1182\/blood-2012-05-431783","volume":"120","author":"J Schwamb","year":"2012","unstructured":"Schwamb J, Feldhaus V, Baumann M, Patz M, Brodesser S, Brinker R, et\u00a0al. B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides. Blood. 2012;120:3978\u201385.","journal-title":"Blood"},{"key":"484_CR19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007545","volume":"14","author":"T Yoshihara","year":"2018","unstructured":"Yoshihara T, Satake H, Nishie T, Okino N, Hatta T, Otani H, et\u00a0al. Lactosylceramide synthases encoded by B4galt5 and 6 genes are pivotal for neuronal generation and myelin formation in mice. PLoS Genet. 2018;14: e1007545.","journal-title":"PLoS Genet"},{"key":"484_CR20","doi-asserted-by":"crossref","first-page":"8182","DOI":"10.1038\/s41598-020-65182-y","volume":"10","author":"N Schomel","year":"2020","unstructured":"Schomel N, Gruber L, Alexopoulos SJ, Trautmann S, Olzomer EM, Byrne FL, et\u00a0al. UGCG overexpression leads to increased glycolysis and increased oxidative phosphorylation of breast cancer cells. Sci Rep. 2020;10:8182.","journal-title":"Sci Rep"},{"key":"484_CR21","volume":"53","author":"Y Hao","year":"2020","unstructured":"Hao Y, Huang Y, Chen J, Li J, Yuan Y, Wang M, et\u00a0al. Exopolysaccharide from Cryptococcus heimaeyensis S20 induces autophagic cell death in non-small cell lung cancer cells via ROS\/p38 and ROS\/ERK signaling. Cell Prolif. 2020;53: e12869.","journal-title":"Cell Prolif"},{"key":"484_CR22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.120.052384","volume":"144","author":"Y Luo","year":"2021","unstructured":"Luo Y, Jiang N, May HI, Luo X, Ferdous A, Schiattarella GG, et\u00a0al. Cooperative binding of ETS2 and NFAT links Erk1\/2 and calcineurin signaling in the pathogenesis of cardiac hypertrophy. Circulation. 2021;144:34\u201351.","journal-title":"Circulation"},{"key":"484_CR23","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.3390\/ijms20092164","volume":"20","author":"S Gallo","year":"2019","unstructured":"Gallo S, Vitacolonna A, Bonzano A, Comoglio P, Crepaldi T. ERK: a key player in the pathophysiology of cardiac hypertrophy. Int J Mol Sci. 2019;20:2164.","journal-title":"Int J Mol Sci"},{"key":"484_CR24","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3858\/emm.2009.41.12.099","volume":"41","author":"JU Jung","year":"2009","unstructured":"Jung JU, Ko K, Lee DH, Ko K, Chang KT, Choo YK. The roles of glycosphingolipids in the proliferation and neural differentiation of mouse embryonic stem cells. Exp Mol Med. 2009;41:935\u201345.","journal-title":"Exp Mol Med"},{"key":"484_CR25","first-page":"351","volume":"12","author":"P Chueakwon","year":"2022","unstructured":"Chueakwon P, Jatooratthawichot P, Talabnin K, Ketudat Cairns JR, Talabnin C. Inhibition of ceramide glycosylation enhances cisplatin sensitivity in cholangiocarcinoma by limiting the activation of the ERK signaling pathway. Life (Basel). 2022;12:351.","journal-title":"Life (Basel)."},{"key":"484_CR26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/pros.24437","volume":"83","author":"R Lin","year":"2023","unstructured":"Lin R, Yang Y, Wu E, Zhou M, Wang S, Zhang Q. SIRT2 promotes cell proliferation and migration through mediating ERK1\/2 activation and lactosylceramide accumulation in prostate cancer. Prostate. 2023;83:71\u201381.","journal-title":"Prostate"},{"key":"484_CR27","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00204-015-1477-x","volume":"89","author":"YK Tham","year":"2015","unstructured":"Tham YK, Bernardo BC, Ooi JY, Weeks KL, McMullen JR. Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets. Arch Toxicol. 2015;89:1401\u201338.","journal-title":"Arch Toxicol"},{"key":"484_CR28","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1158\/2159-8290.CD-22-0535","volume":"13","author":"V Jain","year":"2023","unstructured":"Jain V, Harper SL, Versace AM, Fingerman D, Brown GS, Bhardwaj M, et\u00a0al. Targeting UGCG overcomes resistance to lysosomal autophagy inhibition. Cancer Discov. 2023;13:454\u201373.","journal-title":"Cancer Discov"},{"key":"484_CR29","doi-asserted-by":"crossref","first-page":"7025","DOI":"10.1007\/s00018-021-03958-9","volume":"78","author":"MS Wegner","year":"2021","unstructured":"Wegner MS, Schomel N, Olzomer EM, Trautmann S, Olesch C, Byrne FL, et\u00a0al. Increased glucosylceramide production leads to decreased cell energy metabolism and lowered tumor marker expression in non-cancerous liver cells. Cell Mol Life Sci. 2021;78:7025\u201341.","journal-title":"Cell Mol Life Sci"},{"key":"484_CR30","volume":"42","author":"J Zhang","year":"2023","unstructured":"Zhang J, van der Zon G, Ma J, Mei H, Cabukusta B, Agaser CC, et\u00a0al. ST3GAL5-catalyzed gangliosides inhibit TGF-beta-induced epithelial-mesenchymal transition via TbetaRI degradation. EMBO J. 2023;42: e110553.","journal-title":"EMBO J"},{"key":"484_CR31","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41419-021-04213-6","volume":"12","author":"R Li","year":"2021","unstructured":"Li R, Hao Y, Wang Q, Meng Y, Wu K, Liu C, et\u00a0al. ECHS1, an interacting protein of LASP1, induces sphingolipid-metabolism imbalance to promote colorectal cancer progression by regulating ceramide glycosylation. Cell Death Dis. 2021;12:911.","journal-title":"Cell Death Dis"},{"key":"484_CR32","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol. 2018;15:387\u2013407.","journal-title":"Nat Rev Cardiol"},{"key":"484_CR33","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1161\/CIRCULATIONAHA.121.053575","volume":"144","author":"S Ranjbarvaziri","year":"2021","unstructured":"Ranjbarvaziri S, Kooiker KB, Ellenberger M, Fajardo G, Zhao M, Vander Roest AS, et\u00a0al. Altered cardiac energetics and mitochondrial dysfunction in hypertrophic cardiomyopathy. Circulation. 2021;144:1714\u201331.","journal-title":"Circulation"},{"key":"484_CR34","doi-asserted-by":"crossref","first-page":"9340","DOI":"10.1038\/s41598-022-13390-z","volume":"12","author":"GC Baccam","year":"2022","unstructured":"Baccam GC, Xie J, Jin X, Park H, Wang B, Husson H, et\u00a0al. Glucosylceramide synthase inhibition protects against cardiac hypertrophy in chronic kidney disease. Sci Rep. 2022;12:9340.","journal-title":"Sci Rep"},{"key":"484_CR35","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/s41401-022-01044-9","volume":"44","author":"ZB Li","year":"2023","unstructured":"Li ZB, Jiang L, Ni JD, Xu YH, Liu F, Liu WM, et\u00a0al. Salvianolic acid B suppresses hepatic fibrosis by inhibiting ceramide glucosyltransferase in hepatic stellate cells. Acta Pharmacol Sin. 2023;44:1191\u2013205.","journal-title":"Acta Pharmacol Sin"},{"key":"484_CR36","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/glycob\/cwu020","volume":"24","author":"S Mishra","year":"2014","unstructured":"Mishra S, Chatterjee S. Lactosylceramide promotes hypertrophy through ROS generation and activation of ERK1\/2 in cardiomyocytes. Glycobiology. 2014;24:518\u201331.","journal-title":"Glycobiology"},{"key":"484_CR37","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1194\/jlr.M060061","volume":"57","author":"SA Novgorodov","year":"2016","unstructured":"Novgorodov SA, Riley CL, Yu J, Keffler JA, Clarke CJ, Van Laer AO, et\u00a0al. Lactosylceramide contributes to mitochondrial dysfunction in diabetes. J Lipid Res. 2016;57:546\u201362.","journal-title":"J Lipid Res"},{"key":"484_CR38","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1152\/physrev.00026.2013","volume":"94","author":"DB Zorov","year":"2014","unstructured":"Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev. 2014;94:909\u201350.","journal-title":"Physiol Rev"},{"key":"484_CR39","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/ncb1757","volume":"10","author":"H Nojima","year":"2008","unstructured":"Nojima H, Adachi M, Matsui T, Okawa K, Tsukita S, Tsukita S. IQGAP3 regulates cell proliferation through the Ras\/ERK signaling cascade. Nat Cell Biol. 2008;10:971\u20138.","journal-title":"Nat Cell Biol"},{"key":"484_CR40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s11658-022-00314-y","volume":"27","author":"S Zhu","year":"2022","unstructured":"Zhu S, Wang W, Zhang J, Ji S, Jing Z, Chen YQ. Slc25a5 regulates adipogenesis by modulating ERK signaling in OP9 cells. Cell Mol Biol Lett. 2022;27:11.","journal-title":"Cell Mol Biol Lett"},{"key":"484_CR41","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41419-021-03673-0","volume":"12","author":"D Kumar","year":"2021","unstructured":"Kumar D, Patel SA, Hassan MK, Mohapatra N, Pattanaik N, Dixit M. Reduced IQGAP2 expression promotes EMT and inhibits apoptosis by modulating the MEK-ERK and p38 signaling in breast cancer irrespective of ER status. Cell Death Dis. 2021;12:389.","journal-title":"Cell Death Dis"},{"key":"484_CR42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40659-018-0168-5","volume":"51","author":"M Moniruzzaman","year":"2018","unstructured":"Moniruzzaman M, Ghosal I, Das D, Chakraborty SB. Melatonin ameliorates H(2)O(2)-induced oxidative stress through modulation of Erk\/Akt\/NFkB pathway. Biol Res. 2018;51:17.","journal-title":"Biol Res"},{"key":"484_CR43","volume":"104","author":"H Zhu","year":"2022","unstructured":"Zhu H, Zhang L, Jia H, Xu L, Cao Y, Zhai M, et\u00a0al. Tetrahydrocurcumin improves lipopolysaccharide-induced myocardial dysfunction by inhibiting oxidative stress and inflammation via JNK\/ERK signaling pathway regulation. Phytomedicine. 2022;104: 154283.","journal-title":"Phytomedicine"},{"key":"484_CR44","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153617","volume":"89","author":"H Meng","year":"2021","unstructured":"Meng H, Du Z, Lu W, Wang Q, Sun X, Jiang Y, et\u00a0al. Baoyuan decoction (BYD) attenuates cardiac hypertrophy through ANKRD1-ERK\/GATA4 pathway in heart failure after acute myocardial infarction. Phytomedicine. 2021;89: 153617.","journal-title":"Phytomedicine"},{"key":"484_CR45","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.biocel.2009.08.002","volume":"41","author":"K Lorenz","year":"2009","unstructured":"Lorenz K, Schmitt JP, Vidal M, Lohse MJ. Cardiac hypertrophy: targeting Raf\/MEK\/ERK1\/2-signaling. Int J Biochem Cell Biol. 2009;41:2351\u20135.","journal-title":"Int J Biochem Cell Biol"},{"key":"484_CR46","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41419-017-0239-5","volume":"9","author":"SF Li","year":"2018","unstructured":"Li SF, Zhu CS, Wang YM, Xie XX, Xiao LL, Zhang ZC, et\u00a0al. Downregulation of beta1,4-galactosyltransferase 5 improves insulin resistance by promoting adipocyte commitment and reducing inflammation. Cell Death Dis. 2018;9:196.","journal-title":"Cell Death Dis"},{"key":"484_CR47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13023-017-0565-9","volume":"12","author":"N Guerard","year":"2017","unstructured":"Guerard N, Morand O, Dingemanse J. Lucerastat, an iminosugar with potential as substrate reduction therapy for glycolipid storage disorders: safety, tolerability, and pharmacokinetics in healthy subjects. Orphanet J Rare Dis. 2017;12:9.","journal-title":"Orphanet J Rare Dis"},{"key":"484_CR48","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacc.2020.12.024","volume":"77","author":"M Pieroni","year":"2021","unstructured":"Pieroni M, Moon JC, Arbustini E, Barriales-Villa R, Camporeale A, Vujkovac AC, et\u00a0al. Cardiac involvement in fabry disease: JACC review topic of the week. J Am Coll Cardiol. 2021;77:922\u201336.","journal-title":"J Am Coll Cardiol"},{"key":"484_CR49","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(95)91688-1","volume":"346","author":"A Abrahamov","year":"1995","unstructured":"Abrahamov A, Elstein D, Gross-Tsur V, Farber B, Glaser Y, Hadas-Halpern I, et\u00a0al. Gaucher\u2019s disease variant characterised by progressive calcification of heart valves and unique genotype. Lancet. 1995;346:1000\u20133.","journal-title":"Lancet"}],"container-title":["Cellular &amp; Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-023-00484-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-023-00484-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-023-00484-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T01:02:50Z","timestamp":1700614970000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmbl.biomedcentral.com\/articles\/10.1186\/s11658-023-00484-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["484"],"URL":"https:\/\/doi.org\/10.1186\/s11658-023-00484-3","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]},"assertion":[{"value":"27 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals (Revised 1996) and the rules of Renmin Hospital of Wuhan Hospital were adhered to in all animal experiment protocols in this work (Ethical Number: 20211203C).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}